Already established as cornerstone therapies in diabetes and obesity, GLP-1 receptor agonists have now cracked into the ...

The Real Housewives of Potomac matriarch was found guilty after a two-day trial and more than five hours of jury deliberation, following a March 2024 car accident where she swerved to avoid ...

Viking Therapeutics has seen a significant drop, despite positive news and promising GLP-1 drug developments. Find out why ...

Tyler Perry reminds us that starting therapy is never too late. The director was recently a guest on The View and revealed that he began therapy for the first time at 54. Perry said a question ...

Love was in the air throughout 2024! While some of our favorite celebrity Black couples, like Gabrielle Union and Dwyane Wade, Ciara and Russell Wilson, Steve and Marjorie Harvey, and Jay Z and ...

Two siblings in New Rochelle, NY, are mourning the tragic loss of their parents, who were killed in a fiery car crash earlier this month. Jahmale Ledeatte, 46, and Tracey Ledeatte, 44, were killed ...

Novo Nordisk said on Friday it will begin a new trial of its experimental next-generation CagriSema drug in the first half of ...

A more recent 2024 study — also funded by Novo Nordisk — is currently the longest clinical trial on semaglutide for weight loss. It looked at almost 18,000 participants with excess weight or ...

Novo Nordisk's U.S.-listed shares sank over 19% in premarket trading Friday after releasing trial results for its next generation of weight loss drug, meant to add to its current lineup of Ozempic and ...

Novo Nordisk’s latest attempt in weight loss, a combination drug called CagriSema, matched the bar set by Lilly’s currently ...

Citing 68-week data from the trial, Novo Nordisk (NVO) said that the once-weekly injectable, comprising amylin-analog cagrilintide and its GLP-1 receptor agonist semaglutide, was safe and well ...